A crucial role for glycosylation in modulating tumor immunity has been demonstrated and CHST12-associated DEG pathway analysis suggested that as a member of glycosylation, CHST12 may play a significant role in tumor microenvironment immunity in PAAD tumors. This evidence concerns the gene CHST12 and neoplasm.